This inventor holds 11 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Amgen Inc.. Active years: 2016-2025.
Location History:
- Vashon, WA (US) (2016 - 2023)
- Seattle, WA (US) (2020 - 2024)
Company Filing History:
Years Active: 2016-2025
Title: Unveiling the Inventive Mind of Marc A Gavin
Introduction:
Meet Marc A Gavin, a visionary inventor hailing from Vashon, WA (US), whose innovative spirit has led to the creation of 8 groundbreaking patents. His work at Amgen Inc. has reshaped the landscape of autoimmune disorder treatment with cutting-edge methodologies.
Latest Patents:
Marc's latest patents showcase his expertise in the field of immunosuppressive molecules and T-regulatory cell proliferation. One notable patent focuses on the use of IL-2 variants to treat inflammatory and autoimmune disorders, while another patent introduces IL-2 muteins for the expansion and activation of T-regulatory cells on a large scale.
Career Highlights:
With a keen focus on advancing healthcare solutions, Marc A Gavin has made significant contributions to the biopharmaceutical industry through his patent portfolio. His dedication to innovation and scientific excellence has positioned him as a key player in the development of novel therapeutic approaches.
Collaborations:
In his journey towards inventing cutting-edge solutions, Marc has collaborated with esteemed colleagues such as Li Li and Gunasekaran Kannan. Together, they have brought forth a fusion of diverse expertise to enhance the efficacy of immunosuppressive treatments.
Conclusion:
Marc A Gavin's inventive spirit and dedication to revolutionizing autoimmune disorder treatment through patentable solutions have left a lasting impact on the industry. His collaborations and career highlights serve as a testament to his commitment to advancing healthcare innovations for the betterment of society.